FDA panel: Approve the ‘bionic eye’, with conditions

Second Sight's Argus II bionic eye

An FDA advisory panel recommended that the federal watchdog agency grant a humanitarian device exemption to Second Sight Medical Products’ Argus II retinal prosthesis system, designed for patients who are profoundly blind due to a rare condition called retinitis pigmentosa.

Patients with retinitis pigmentosa have either bare light perception or none at all. There is currently no cure and no available treatment for the rare condition that’s diagnosed about 250 times each year.

The Ophthalmic Devices Panel’s recommendation, which the FDA is not obliged to follow, came with a caveat: Second Sight should be compelled to run a rigorous post-approval study because of the significant risks posed by the device.

A majority of panelists, 17-2, agreed that Argus II demonstrated a reasonable assurance of safety even though different versions of two device configurations were implanted in 30 subjects in the clinical trial; no subjects were implanted with the version of the device proposed for marketing because modifications were made to the implant’s application specific circuit chip, suture tab and carrier frequency; the testing was non-randomized; evaluators were unmasked; numerous modifications were made to the study protocol during the course of study; and there were a number of protocol deviations.

Indiana School of Optometry’s William Swanson cast dissenting votes on the questions of safety and reasonable assurance of probable benefit, though he agreed the probable benefits outweighed the risks.

"There are people who are not going to benefit; we don’t know who they are. There are people who are going to lose their eye, there are some people who are going to lose 2 eyes," Swanson said. "So I really couldn’t say it was safe and I couldn’t say it was effective, but I do feel that for the patient population at risk, there is a possible benefit, even though it’s not for everybody."

Swanson suggested that the patient brochure not oversell Argus II and that it more directly inform patients of the adverse events experienced by patients in the clinical trial.

"I think it’s important to emphasize that this will provide low vision rather than some, partial vision," said Alvin Eisner of Northwest Sarcoma Foundation. "The expectations have to be realistic."

The data show that with the Argus II "mobility is not really clear, but orientation seems to be something that is the greatest benefit … and as we’ve heard, orientation (knowing where you and others are in space) is extremely important, even if it doesn’t help you walk," Swanson noted.

The panel agreed on a 5-to-10-year post-approval study including both follow-up of patients in whom the device has already been implanted and a well-controlled study of a new group of patients. Safety, stability and utility topped the list of concerns.

Panelists asked that the post-approval study include a close assessment of adverse events, reliability of the Argus II device, visual function measures and some quality assurance controls related to measurements of those assessments.

"We really need to have a careful recording of what the adverse events truly are, because the evaluation of the adverse events, whether they are serious or not serious, was sort of somewhat flippantly done in the past," stressed Saint Louis University School of Medicine’s Dr. Stephen Feman. "There was a patient, for example, recorded who went blind. That was not listed as a serious adverse event because the patient went blind in both eyes … yet some might say that’s a serious adverse event. Maybe the intervention caused the blindness in both eyes."

RSS From Medical Design & Outsourcing

  • A few ideas for improving productivity in medical processes
    Drive-based vibration and slosh control can help improve throughput in machines that assemble medical devices and products. Bipin Sen • Ed Lasch Bosch Rexroth Corporation www.boschrexroth-us.com Simply increasing the speed of a system that assembles medical devices, or packages medical products, seems like an easy way to boost throughput – until unwanted vibration (either induced […]
  • ODU announces MEDI-SNAP EMC for next generation medical applications
    ODU, announced ODU MEDI-SNAP EMC, the advanced shielded plastic connector solutions to the US market. ODU MEDI-SNAP EMC is the newest addition to ODU’s Push-Pull circular connectors. The advanced medical connector solution is lightweight, autoclavable, sterilizable and it offers a touch proofed housing and reliable EMI protection at the same time. ODU MEDI-SNAP EMC is available in […]
  • Evaluating the risk of device misconnections: Designing for medical devices with ISO 80369 in mind
    Beginning in the 1990s, concerns grew regarding the proliferation of medical devices fitted with luer connectors and the reports of patient injuries and deaths arising from misconnections. Thus began a many-years process to develop new industry standards for the small-bore connectors used in medical device applications. The much-anticipated ISO 80369 series of standards for small-bore […]
  • Custom molded filter screen assemblies limit contamination and reduce product failure
    Molded screen insert assemblies from Minnesota Rubber and Plastics are custom designed for water, beverage, off-highway and transportation applications to filter out fluid contaminants and reduce product failure. A wide range of screen options are available in many materials for difficult filtration applications allowing use with different fluids. Filter assembly orifice sizes available range from .71 […]
  • Anomet Platinum-Clad Tantalum wire designed for Implantable medical devices
    Anomet Products custom manufactures a special clad composite wire that is biocompatible, strong, and corrosion-resistant for use in fabricating implantable medical devices. Anomet Platinum-Clad Tantalum Wire combines the properties of each alloy to provide a biocompatible, high-strength, and corrosion resistant radiopaque wire for use in short-term and long-term implantable medical devices. Suitable for coils, electrodes, leads, […]
  • Finding the best way to join plastic components
    When designing an assembly method for the plastic components in a medical device, stay process-neutral and weigh the advantages and disadvantages of the available methods. As the medical device industry continues the rapid development of complex, innovative products, the need for joining plastic components is keeping pace. These requirements range from micro-scale tubes to macro […]
  • Multidisciplinary Centre for Research into Obesity opens in Sao Paulo
    Researchers, clinicians, health educators and policy makers all gathered on May 4th in Sao Paulo, Brazil, as the new Multidisciplinary Centre for Research into Obesity and Related Comorbidities (Cepid-OCRC) was opened at da Universidade Estadual de Campinas (UNICAMP). At the heart of the new facility is a 3D imaging laboratory with a Bruker PET/SPECT/CT imaging […]
  • Building lean bodies and programs at UNC Health Care
    In the healthcare industry, employees are constantly seeking ways to continuously improve and increase the quality and safety of a facility. UNC Health Care, awarded 19 times for its leadership in quality and safety, came to Magnatag for products to implement its recent lean six-sigma projects in its OB/GYN department. “I am using the Magnatag […]
  • How lifting columns improve patients’ experience
    Vertical lifts are required in a wide range of medical equipment where accessibility and comfort improves care and patient outcomes. Applications such as wheelchair lifts, examination tables, dental chairs, adjustable nurses’ stations, and optician instruments all require vertical lifts to provide appropriate care and an optimal patient experience. Designers of medical equipment need lifting columns […]
  • Patent Protection
    In today’s innovation economy, a medical device company’s success depends on the strength and value of its patent portfolio. Recent statistics from the U.S. Patent & Trademark Office (USPTO) show the issue rate for new medical device patents is exploding. In fact, the number of medical device patents issued by the USPTO has increased each […]
  • It's a sellers' market at all levels of the medtech industry
    Ken Fine, co-founder and president of Proven Process, is a popular man these days. Not a week goes by without Fine entertaining flirtations from private equity investors or potential strategic partners, looking to see if he's ready to cash out of his business after 21 years. Proven Process is a Mansfield, Mass.-based contract manufacturer providing […]

Leave a Reply